Artemis Investment Management’s Medtronic MDT Stock Holding History

Artemis Investment Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-46,801	Closed	-$4.23K	–	266
2020 Q1	$4.23K	Sell	46,801 -12,841	-22%	-$1.37M	0.01%	179
2019 Q4	$6.76M	Sell	59,642 -4,031	-6%	-$442K	0.09%	185
2019 Q3	$6.91M	Sell	63,673 -23,657	-27%	-$2.47M	0.09%	194
2019 Q2	$8.5M	Sell	87,330 -80,254	-48%	-$7.33M	0.1%	202
2019 Q1	$15.3M	Sell	167,584 -624,481	-79%	-$55.9M	0.18%	155
2018 Q4	$72.1M	Buy	+792,065	New	+$74M	0.94%	28
2015 Q2	–	Sell	-47,500	Closed	-$3.71M	–	263
2015 Q1	$3.71M	Buy	+47,500	New	+$3.6M	0.15%	145

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Artemis Investment Management's MDT Position: Q2 2020 in Review

Artemis Investment Management sold out of Medtronic (MDT) in Q2 2020, closing a stake of 46,801 shares — an estimated $4.23K sold.

Artemis Investment Management first reported a position in MDT in Q1 2015 and held it in 7 quarters. The position peaked at $72.1M in Q4 2018. 1,759 funds tracked by Wall St. Rank hold MDT as of Q2 2020.

Artemis Investment Management reported no remaining Medtronic position as of Q2 2020 after selling out during the quarter.
Artemis Investment Management sold 46,801 Medtronic shares in Q2 2020, an estimated $4.23K.
Artemis Investment Management first reported a position in Medtronic in Q1 2015 and held it in 7 quarters.
Artemis Investment Management's Medtronic position peaked at $72.1M in Q4 2018.
1,759 funds tracked by Wall St. Rank held Medtronic as of Q2 2020.

Based on Artemis Investment Management's 13F filing for Q2 2020, filed 27 Jul 2020.